⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
House Dust Mite Disease Market to Exhibit Substantial Growth at a CAGR of 3.5% During the Forecast Period (2025-2034) | DelveInsight USA - English USA - English
prnewswire.com
ALKS
STG
GSK
SNY
TEVA
AZN
INCY
REGN
PFE
BMY
LLY
AMGN
ABBV
GILD
BIIB
CSL
VRTX
BHC
NVS
MRK
LEO
ALLT
CNTB
INM
Flashpoint Therapeutics Appoints Venkat R. Krishnamurthy, Ph.D. as Chief Scientific Officer
businesswire.com
LLY
AZN
XCUR
Strive Compounding Pharmacy Files Landmark Antitrust Lawsuit Against Eli Lilly and Novo Nordisk
prnewswire.com
LLY
NVO
Peptide Therapeutics Market Report 2025-2035: Industry to Experience Robust Growth with a CAGR of 6.8% Through 2035 - Subcutaneous Route to Command Over 65% Share - ResearchAndMarkets.com
businesswire.com
APLS
BLRX
LLY
NTRA
NVO
PLTK
ZBRA
TMates Review 2026: GLP-1 Telehealth, Pricing & Safety
accessnewswire.com
NVO
LLY
Morgan & Morgan Reports Landmark 2025 Trial Results, Highlighting Billions Recovered for Clients
globenewswire.com
GOOGL
NSC
LLY
Shed Expands GLP-1 Weight-Loss Offerings with Wegovy® Pills via NovoCare
prnewswire.com
NVGS
LLY
Macrophage Activation Syndrome Market in the 6MM to Witness Upsurge in Growth at a CAGR of 24.7% During the Forecast Period (2025-2034) | DelveInsight
prnewswire.com
NVS
BIIB
VTRS
UCB
BMY
ABBV
REGN
SNY
LLY
JNJ
HOPE
GCBC
AMGN
TAK
Systemic Lupus Erythematosus Market to Exhibit Growth at a CAGR of 9.4% During the Forecast Period (2025–2034) Owing to Rising Use of Biologics – Approvals of BENLYSTA and SAPHNELO, Plus a Strong Pipeline | DelveInsight
globenewswire.com
JNJ
BIIB
NVS
VTRS
RPRX
ABBV
AZN
MRK
RIGL
GSK
REGN
GILD
AMGN
LLY
BMY
XBI
IBB
Adimab Records Another Year of Double-Digit Clinical Program Growth
prnewswire.com
GSK
BIIB
NVS
BMY
REGN
VRTX
LLY
MRK
ALNY
IVVD
ALE
SCHR